996 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Nascent Biotech Competitors or Alternatives

Nascent Biotech's top competitors include NexImmune, Bolt and Perthera.

Unlock 27 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Nascent Biotech's company profile

Sean Carrick

CEO

90/100
2
$5.4M
$ < 1M
  • $5.4M
    $ < 1M
  • 2
    $5.4M
  • $ < 1M
  • 90/100
  • 2
  • $5.4M
  • $ < 1M
View ProfileView
1
Nascent Biotech's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
2
Nascent Biotech's Competitor - Bolt logo

Willie Quinn

President & CEO

82/100
90
$447.6M
$4.2M
  • $447.6M
    $4.2M
  • 90
    $447.6M
  • $4.2M
  • 82/100
  • 90
  • $447.6M
  • $4.2M
View ProfileView
3
Nascent Biotech's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
4
Nascent Biotech's Competitor - AstraZeneca logo

Pascal Soriot

CEO

66/100
94,300
$100M
$57.2B
  • $100M
    $57.2B
  • 94,300
    $100M
  • $57.2B
  • 66/100
  • 94,300
  • $100M
  • $57.2B
View ProfileView
5
Nascent Biotech's Competitor - Bristol-Myers Squibb logo

Christopher Boerner

CEO

53/100
34,300
$23.5B
$48B
  • $23.5B
    $48B
  • 34,300
    $23.5B
  • $48B
  • 53/100
  • 34,300
  • $23.5B
  • $48B
View ProfileView
Nascent Biotech's top 30 competitors are NexImmune, Bolt, Perthera, Novartis, AstraZeneca, Bristol-Myers Squibb, Aura, Roche, Puma Biotechnology, Mustang Bio, Adaptimmune, bluebird bio, Centrose, Fate Therapeutics, Gilead Sciences, MacroGenics, Merus, Immatics, Zymeworks, Iovance, Ambrx, Atara, Amgen, Daiichi Sankyo, Marker Therapeutics, SQZ Biotech, Moderna, BioNTech, Johnson & Johnson and Linnaeus. Together they have raised over 58.9B between their estimated 537.7K employees. Nascent Biotech has 2 employees and is ranked 31th among it's top 10 competitors. The top 10 competitors average 17,346.

Nascent Biotech VS NexImmune

NexImmune is seen as one of Nascent Biotech's biggest rivals. NexImmune was founded in 2011 in Gaithersburg, Maryland. Like Nascent Biotech, NexImmune also operates in the Biotechnology sector. NexImmune generates $ less revenue than Nascent Biotech.

Nascent Biotech VS Bolt

Bolt is one of Nascent Biotech's top competitors. Bolt was founded in 2015, and its headquarters is in Redwood City, California. Like Nascent Biotech, Bolt also operates in the Biotechnology space. Bolt has 88 more employees than Nascent Biotech.

Nascent Biotech VS Perthera

Perthera is one of Nascent Biotech's top rivals. Perthera was founded in 2012, and is headquartered in McLean, Virginia. Like Nascent Biotech, Perthera also works within the Pharmaceuticals & Biotechnology sector. Perthera generates $3.3M more revenue vs. Nascent Biotech.

Looking for similar companies to Nascent Biotech?

Similar Companies

Companies in Vero Beach with employees in 1-25 range

See 108 companies 
Biotechnology companies in Miami Metropolitan Area

See 228 companies 
Companies in Vero Beach with revenue in $100K-5.0M range

See 258 companies 
Pharmaceuticals & Biotechnology companies in Miami Metropolitan Area

See 419 companies 
Biotechnology companies in Florida

See 552 companies 
Pharmaceuticals & Biotechnology companies in Florida

See 979 companies 
Biotechnology companies with employees in 1-25 range

See 3,311 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,525 companies 
Pharmaceuticals & Biotechnology companies with employees in 1-25 range

See 4,689 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Nascent Biotech and Nascent Biotech's Competitors

November 11, 2025Pharmabiz
Roche announced that the first phase III (FENhance 2) of two pivotal, similarly─designed phase III studies (FENhance 1 and 2) in patients with relapsin...
November 11, 2025Pharmaceutical Business Review
The new site increases capacity and strengthens the company's supply chain capabilities for RLTs in the US. The facility in Carlsbad, filed with the US...
November 10, 2025Indian Pharma Post
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy...
November 10, 2025Pharmabiz
Gilead Sciences, Inc. announced the phase 3 ASCENT─07 study investigating Trodelvy (sacituzumab govitecan─hziy) versus chemotherapy as a first─line tre...
November 10, 2025Indian Pharma Post
The offering is expected to close on November 10, 2025, subject to customary closing conditions...
November 10, 2025Seeking Alpha
November 10, 2025Marketscreener
(Reuters) -Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make cancer treatments, a...
November 10, 2025Investing.com
Roche reports major phase III success for multiple sclerosis drug Fenebrutinib...
November 10, 2025FinanzNachrichten
LONDON (dpa-AFX) - AstraZeneca PLC (AZN, AZN.L) announced results from its Bax24 Phase III trial, revealing that baxdrostat significantly reduced 24-ho...
November 10, 2025Indian Pharma Post
While the trial fell short of demonstrating a statistically significant PFS benefit compared to chemotherapy, early data suggest a potential overall su...

Frequently Asked Questions about Nascent Biotech

  1. Who are Nascent Biotech's top competitors?

    Nascent Biotech's top 3 competitors are NexImmune, Bolt, Perthera.

  2. Who is similar to Nascent Biotech?

    NexImmune is the most similar to Nascent Biotech. Bolt and Perthera are also similar to Nascent Biotech.

  1. Are Nascent Biotech and NexImmune competitors?

    Yes, NexImmune is one of Nascent Biotech’s top competitors.